Northeastern researchers have created an adhesive hydrogel that is 15 times stronger than current options for repairing nerve damage. The hydrogel could replace sutures, offering a better way to regenerate nerves that control muscle feeling and movement.

Some countries take months or even years to approve drugs. Northeastern researcher Jared Auclair trains regulators around the world to help speed up this process.

The deadly strain of leishmaniasis infects 300,000 people annually, causing 20,000 deaths, and is the second largest cause of parasitic death after malaria. For two Northeastern professors, Richard Wamai and Michael Pollastri, controlling the disease is a top priority.

The deadly strain of leishmaniasis infects 300,000 people annually, causing 20,000 deaths, and is the second largest cause of parasitic death after malaria. For two Northeastern professors, Richard Wamai and Michael Pollastri, controlling the disease is a top priority.

The three-story, 104,000 square-foot building will feature research labs, a meeting area for workshops, and a makerspace with a suite of high-tech equipment.

The three-story, 104,000 square-foot building will feature research labs, a meeting area for workshops, and a makerspace with a suite of high-tech equipment.

Co-op Coordinator Vanecia Harrison-Sanders took part in a panel discussion about diversity in life sciences during the annual MassBioEd's conference.

With the sprawling of suburbia comes unwanted new neighbors. Ticks are no longer only dwellers of the deep forest—they can be found in cities, too, said University Distinguished Professor Kim Lewis at Northeastern. His lab is working to develop a cure for chronic Lyme disease, which develops in a subset of people diagnosed with Lyme disease.

Dr. Richard Saferstein was a member of the Northeastern community for many years. Last month, the Barnett Institute honored his memory with a newly created award.

Northeastern Chemistry and Chemical Biology Professor and George Behrakis Chair of Pharmaceutical Biotechnology Alex Makriyannis has made a name for himself in the discovery of this important system and the pharmacological advancements that can come out of it. This spring, in recognition of his vital research, Makriyannis is being named the 2018 Nathan B. Eddy Awardee by the College on Problems of Drug Dependence (CPDD) and will be receiving an…

Daniel Bassous, MS in Biotechnology student, sits down with the College of Science Graduate Program staff to talk about what it's like to work and study at Northeastern University.

Professor John R. Engen and Professor Timothy Springer of Harvard Medical School publish paper about the molecular basis of Myostatin activation.

Northeastern has partnered with global pharmaceutical company GlaxoSmithKline to launch a first-of-its-kind, joint experiential PhD program. Employees of GSK who enroll in the program will conduct pharmaceutical research projects co-developed by the company and Northeastern, and GSK will cover the tuition costs of the program as well as all the research expenses.

Northeastern's Biopharmaceutical Analysis Training Lab was just named a training partner for the International Council for Harmonization (ICH), an organization which creates standardized guidelines for drug regulation processes in countries around the world. Professor and Director of the BATL Jared Auclair led the first pilot training session in October on Quality 1 stability guidelines for protein and small molecule stability.